Safety issues of tirzepatide (pancreatitis and gallbladder or biliary disease) in type 2 diabetes and obesity: a systematic review and meta-analysis
They improve blood sugar control, modestly lower blood pressure, may improve lipid and vascular function, and seem to reduce inflammation and atherosclerotic plaque growth and progression, Glatter told Healthline
In countries where patents have expired, weve seen a rush of generics, so as that comes to the U.S
However, adding GIP agonism significantly enhances results, suggesting GIP contributes meaningfully to overall weight loss through metabolic effects beyond pure appetite control
The diarrhea came on suddenly during a work meeting and I had to excuse myself twice
The abdomen is the most common injection site for beginners